Indacaterol/glycopyrronium bromide/mometasone
Indacaterol/glycopyrronium bromide/mometasone
Indacaterol/glycopyrronium bromide/mometasone is a combination medication used in the management of chronic obstructive pulmonary disease (COPD) and asthma. This combination includes three active ingredients: indacaterol, glycopyrronium bromide, and mometasone furoate, each contributing to the therapeutic effects of the medication.
Pharmacology[edit]
Indacaterol[edit]
Indacaterol is a long-acting beta-2 adrenergic agonist (LABA). It works by stimulating beta-2 adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation. This helps to relieve symptoms such as shortness of breath and wheezing in patients with COPD and asthma.
Glycopyrronium Bromide[edit]
Glycopyrronium bromide is a long-acting muscarinic antagonist (LAMA). It blocks the action of acetylcholine on muscarinic receptors in the airway smooth muscle, resulting in bronchodilation. This action complements the effects of indacaterol, providing a more comprehensive bronchodilatory effect.
Mometasone Furoate[edit]
Mometasone furoate is a corticosteroid with anti-inflammatory properties. It reduces inflammation in the airways, decreasing the frequency and severity of asthma attacks and COPD exacerbations. Mometasone works by inhibiting multiple inflammatory cytokines and mediators.
Indications[edit]
Indacaterol/glycopyrronium bromide/mometasone is indicated for the maintenance treatment of patients with COPD and asthma who require a combination of a LABA, a LAMA, and an inhaled corticosteroid (ICS) to manage their symptoms and reduce the risk of exacerbations.
Administration[edit]
The medication is typically administered via inhalation using a dry powder inhaler. Patients are advised to use the inhaler as prescribed by their healthcare provider, usually once daily.
Side Effects[edit]
Common side effects of indacaterol/glycopyrronium bromide/mometasone may include:
- Headache
- Nasopharyngitis
- Cough
- Oropharyngeal pain
Serious side effects can include:
- Paradoxical bronchospasm
- Hypersensitivity reactions
- Cardiovascular effects such as palpitations and tachycardia
Contraindications[edit]
This combination medication is contraindicated in patients with a known hypersensitivity to any of its components. It should be used with caution in patients with cardiovascular disorders, glaucoma, urinary retention, and other conditions that may be exacerbated by the medication's effects.
Also see[edit]
- Chronic obstructive pulmonary disease
- Asthma
- Beta-2 adrenergic agonist
- Muscarinic antagonist
- Corticosteroid
| Indacaterol/glycopyrronium bromide/mometasone | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
